473 lines
21 KiB
Plaintext
473 lines
21 KiB
Plaintext
|
Subject: The End of Psychedelic Exploration - from Slothrop
|
||
|
|
Homage To: Shulgin's Psychedelic Publications
|
||
|
|
|
||
|
|
Alexander Shulgin is the worlds foremost developer and explorer of
|
||
|
|
psychedelic drugs. He has been, and remains, a prolific writer. His
|
||
|
|
publications provide a great introduction to the diverse world of
|
||
|
|
psychedelics, and provide and inspiration for psychedelic exploration.
|
||
|
|
However, Shulgin has informed me that the publishing of any
|
||
|
|
human data on new compounds had to stop abruptly with the enactment
|
||
|
|
of the Analogue Drug Bill in 1986. This particular bit of obscenity
|
||
|
|
makes the generation, or even the attempted generation, of any altered
|
||
|
|
state of consciousness a felonious act. The continuing publication of
|
||
|
|
experimental results in the medical and scientific literature is now
|
||
|
|
totally impossible. For this reason I think it is worthwhile to
|
||
|
|
provide a complete list of his psychedelic publications. They are
|
||
|
|
well referenced, and can lead to much other psychedelic literature.
|
||
|
|
|
||
|
|
Shulgin crossed the diamond with the pearl and gave birth to all forms of
|
||
|
|
light: "It is early morning now. Slothrop's breath is white on the air.
|
||
|
|
He is just up from a dream. Part I of a poem, with woodcuts accompanying
|
||
|
|
the text - a woman is attending a dog show which is also, in some way, a
|
||
|
|
stud service. She has brought her Pekingese, a female with a sickeningly
|
||
|
|
cute name, Mimsy or Goo-Goo or something, here to be serviced. She is
|
||
|
|
passing the time in a garden setting, with some other middle-class ladies
|
||
|
|
like herself, when from some enclosure nearby she hears the sound of
|
||
|
|
her bitch, coming. The sound goes on and on for much longer than
|
||
|
|
seems appropriate, and she suddenly realizes that the sound is her own
|
||
|
|
voice, this interminable cry of dog-pleasure. The others, politely, are
|
||
|
|
pretending not to notice. She feels shame, but is helpless, driven now by
|
||
|
|
a need to go out and find other animal species to fuck. She sucks the
|
||
|
|
penis of a multicolored mongrel who has tried to mount her in the
|
||
|
|
street. Out in a barren field near a barbed-wire fence, winter fires across
|
||
|
|
the clouds, a tall horse compels her to kneel, passively, and kiss his
|
||
|
|
hooves. Cats and minks, hyenas and rabbits, fuck her inside automo-
|
||
|
|
biles, lost at night in the forests, out beside a waterhole in the desert.
|
||
|
|
|
||
|
|
"As Part II begins, she has discovered she's pregnant. Her husband, a
|
||
|
|
dumb, easygoing screen door salesman, makes an agreement with her:
|
||
|
|
her own promise is never stated, but in return, nine months from now,
|
||
|
|
he will take her where she wants to go. So it is that close to the end of
|
||
|
|
her term he is out on the river, and American river, in a rowboat, hauling
|
||
|
|
on the oars, carrying her on a journey. The key color in this section is
|
||
|
|
violet.
|
||
|
|
|
||
|
|
"Part III finds her at the bottom of the river. She has drowned. But all
|
||
|
|
forms of life fill her womb. 'Using her as mermaid' (line 7), they trans-
|
||
|
|
port her down through these green river-depths. 'It was down, and out
|
||
|
|
again./ Old Squalidozzi, ploughman of the deep,/ At the end of his
|
||
|
|
day's sowing/ Sees her verdigris belly among the weeds' (lines 10-13),
|
||
|
|
and brings her back up. He is a classically-bearded Neptune figure with
|
||
|
|
an old serene face. From out of her body streams a flood now of dif-
|
||
|
|
ferent creatures, octopuses, reindeer, kangaroos, 'Who can say all the
|
||
|
|
life/ That left her womb that day?' Squalidozzi can only catch a
|
||
|
|
glimpse of the amazing spill as he bears her back toward the surface.
|
||
|
|
Above, it is a mild and sunlit green lake or pond, grassy at the banks,
|
||
|
|
shaded by willows. Insects whine and hover. The key color now is
|
||
|
|
green. 'And there as it broke to sun/ Her corpse found sleep in the
|
||
|
|
water/ And in the summer depths/ The creatures took their way/ Each
|
||
|
|
to its proper love/ In the height of afternoon/ As the peaceful river
|
||
|
|
went....'" Pynchon (1973, p. 446-447)
|
||
|
|
|
||
|
|
For reprints of Shulgin's publications, write to:
|
||
|
|
|
||
|
|
Alexander T. Shulgin
|
||
|
|
1483 Shulgin Road
|
||
|
|
Lafayette, CA 94549
|
||
|
|
|
||
|
|
Be merciful. He is out of many of the older papers, and probably doesn't
|
||
|
|
have reprints of the longer review articles. Don't request reprints of
|
||
|
|
articles that you can get at the library. After each article I have
|
||
|
|
included a number. These are the numbers that Shulgin uses to reference
|
||
|
|
his papers. If you include these it will make it easier for him to
|
||
|
|
locate them. I have the references in troff format. For those not
|
||
|
|
familiar with this format, I include a list of the format commands.
|
||
|
|
|
||
|
|
\fI start italics
|
||
|
|
\fG start greek
|
||
|
|
\fR end italics or greek
|
||
|
|
\u shift up half line, begin superscript or end subscript
|
||
|
|
\d shift down half line, begin subscript or end superscript
|
||
|
|
\s+2 increase point size by two
|
||
|
|
\s-2 decrease point size by two
|
||
|
|
\*' accent on preceding letter
|
||
|
|
\*: umlaut on preceding letter
|
||
|
|
|
||
|
|
.XP
|
||
|
|
Pynchon, Thomas. 1973. Gravity's Rainbow. The Viking Press, N.Y. Pp. 760.
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T., S. Bunnell, and T. Sargent. 1961. The psychotomimetic
|
||
|
|
properties of 3,4,5-trimethoxyamphetamine. Nature 189: 10011-1012. 12
|
||
|
|
.XP
|
||
|
|
_____. 1963. Psychotomimetic agents related to mescaline. Experientia
|
||
|
|
19: 127. 19
|
||
|
|
.XP
|
||
|
|
_____. 1963. Composition of the myristicin fraction from oil of nutmeg.
|
||
|
|
Nature 197: 379. 20
|
||
|
|
.XP
|
||
|
|
_____. 1963. Concerning the pharmacology of nutmeg. Mind 1: 299-302. 23
|
||
|
|
.XP
|
||
|
|
_____. 1964. 3-methoxy-4,5-methylenedioxy amphetamine, a new
|
||
|
|
psychotomimetic agent. Nature 201: 1120-1121. 29
|
||
|
|
.XP
|
||
|
|
_____. 1964. Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines
|
||
|
|
Experientia 20: 366. 30
|
||
|
|
.XP
|
||
|
|
_____, and H. O. Kerlinger. 1964. Isolation of methoxyeugenol and trans-
|
||
|
|
isoelemicin from oil of nutmeg. Naturwissenschaften 15: 360-361. 31
|
||
|
|
.XP
|
||
|
|
_____. 1965. Synthesis of the trimethoxyphenylpropenes. Can. J. Chem.
|
||
|
|
43: 3437-3440. 43
|
||
|
|
.XP
|
||
|
|
_____. 1966. Possible implication of myristicin as a psychotropic substance
|
||
|
|
Nature 210: 380-384. 45
|
||
|
|
.XP
|
||
|
|
_____. 1966. The six trimethoxyphenylisopropylamines
|
||
|
|
(trimethoxyamphetamines). J. Med. Chem. 9: 445-446. 46
|
||
|
|
.XP
|
||
|
|
_____, T. Sargent, and C. Naranjo. 1966. Role of 3,4-dimethoxyphenethylamin
|
||
|
|
in schizophrenia. Nature 212: 1606-1607. 48
|
||
|
|
.XP
|
||
|
|
_____, T. Sargent, and C. Naranjo. 1967. The chemistry and psychopharmacolo
|
||
|
|
of nutmeg and of several related phenylisopropylamines. \fIIn\fR D. H.
|
||
|
|
Efron [ed.]: Ethnopharmacologic search for psychoactive drugs. U. S. Dept.
|
||
|
|
of H. E. W., Public Health Service Publication No. 1645. Pp. 202-214.
|
||
|
|
Discussion: ibid. pp. 223-229. 49
|
||
|
|
.XP
|
||
|
|
_____, and T. Sargent. 1967. Psychotropic phenylisopropylamines derived
|
||
|
|
from apiole and dillapiole. Nature 215: 1494-1495. 50
|
||
|
|
.XP
|
||
|
|
Sargent, T. W., D. M. Israelstam, A. T. Shulgin, S. A. Landaw, and N. N.
|
||
|
|
Finley. 1967. A note concerning the fate of the 4-methoxyl group in
|
||
|
|
3,4-dimethoxyphenethylamine (DMPEA). Biochem. Biophys. Res. Commun.
|
||
|
|
29: 126-130. 52
|
||
|
|
.XP
|
||
|
|
Naranjo, C., A. T. Shulgin, and T. Sargent. 1967. Evaluation of
|
||
|
|
3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy.
|
||
|
|
Med. Pharmacol. Exp. 17: 359-364. 53
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1968. The ethyl homologs of 2,4,5-trimethoxyphenylisopropyl-
|
||
|
|
amine. J. Med. Chem. 11: 186-187. 54
|
||
|
|
.XP
|
||
|
|
_____, T. Sargent, and C. Naranjo. 1969. Structure activity relationships
|
||
|
|
of one-ring psychotomimetics. Nature 221: 537-541. 57
|
||
|
|
.XP
|
||
|
|
_____. 1969. Recent developments in cannabis chemistry. J. Psyched. Drugs
|
||
|
|
2: 15-29. 58
|
||
|
|
.XP
|
||
|
|
_____. 1969. Psychotomimetic agents related to the catecholamines.
|
||
|
|
J. Psyched. Drugs 2(2): 12-26. 59
|
||
|
|
.XP
|
||
|
|
_____. 1970. Chemistry and structure-activity relationships of the
|
||
|
|
psychotomimetics. \fIIn\fR: D. H. Efron [ed.]. Psychotomimetic Drugs.
|
||
|
|
Raven Press, New York. Pp. 21-41. 60
|
||
|
|
.XP
|
||
|
|
_____. 1970. The mode of action of psychotomimetic drugs; some qualitative
|
||
|
|
properties of the psychotomimetics. Neur. Res. Prog. Bull. 8: 72-78. 61
|
||
|
|
.XP
|
||
|
|
_____. 1970. 4-alkyl-dialkoxy-\fGa\fR-methyl-phenethylamines and their
|
||
|
|
pharmacologically-acceptable salts. U. S. Patent 3,547,999, issued Dec. 15,
|
||
|
|
1970. 63
|
||
|
|
.XP
|
||
|
|
_____, T. Sargent, and C. Naranjo. 1971. 4-bromo-2,5-dimethoxyphenyliso-
|
||
|
|
propylamine, a new centrally active amphetamine analog. Pharmacology
|
||
|
|
5: 103-107. 64
|
||
|
|
.XP
|
||
|
|
_____. 1971. Chemistry and sources. \fIIn\fR: S. S. Epstein [ed].
|
||
|
|
Drugs of abuse: their genetic and other chronic nonpsychiatric hazards.
|
||
|
|
The MIT Press, Cambridge, Mass. Pp 3-26. 65
|
||
|
|
.XP
|
||
|
|
_____. 1971. Preliminary studies of the synthesis of nitrogen analogs
|
||
|
|
of \fGD\fR\u\s-21\s+2\d-THC. Acta Pharm. Suec. 8: 680-681. 66
|
||
|
|
.XP
|
||
|
|
_____. 1972. Hallucinogens, CNS stimulants, and cannabis. \fIIn\fR:
|
||
|
|
S. J. Mule/*' and H. Brill [eds.]: Chemical and biological aspects of
|
||
|
|
drug dependence. CRC Press, Cleveland, Ohio. Pp. 163-175. 67
|
||
|
|
.XP
|
||
|
|
_____. 1973. Stereospecific requirements for hallucinogenesis.
|
||
|
|
J. Pharm. Pharmac. 25: 271-272. 68
|
||
|
|
.XP
|
||
|
|
_____. 1973. Mescaline: the chemistry and pharmacology of its analogs.
|
||
|
|
Lloydia 36: 46-58. 69
|
||
|
|
.XP
|
||
|
|
_____. 1973. The narcotic pepper - the chemistry and pharmacology of
|
||
|
|
\fIPiper methysticum\fR and related species. Bull. Narc. 25: 59-74.
|
||
|
|
Le poivre stupe\*'fiant - chemie et pharmacologie du \fIPiper methysticum\fR
|
||
|
|
et des espe\*'ces apparente\*'es. Bull. Stupe\*'fiants 25: 61-77. 70
|
||
|
|
.XP
|
||
|
|
_____, T. Sargent, and C. Naranjo. 1973. Animal pharmacology and human
|
||
|
|
psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine
|
||
|
|
(MMDA). Pharmacology 10: 12-18. 71
|
||
|
|
.XP
|
||
|
|
_____. Drugs of abuse in the future. Drug abuse in America Vol. 1.
|
||
|
|
pp. 209-236. U.S.G.P.O. 5266-00004. Reprinted: Clin. Tox. 8: 405-456. 72
|
||
|
|
.XP
|
||
|
|
Kalbhen, D. A., T. Sargent, A. T. Shulgin, G. Braun, H. Stauffer, N. Kusubov,
|
||
|
|
and M. L. Nohr. 1974. Human pharmacodynamics of the psychodysleptic
|
||
|
|
4-bromo-2,5-dimethoxyphenylisopropylamine labelled with \u82\dBr.
|
||
|
|
IRCS (Int. Res. Comm. Sys.) 2: 1091. 73
|
||
|
|
.XP
|
||
|
|
Sargent, T., D. A. Kalbhen, A. T. Shulgin, H. Stauffer, and N. Kusubov. 1975
|
||
|
|
A potential new brain-scanning agent: 4-\u77\dBr-2,5-dimethoxyphenyliso-
|
||
|
|
propylamine (4-Br-DPIA). J. Nucl. Med. 16: 243-245. 74
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T., and M. F. Carter. 1975. Centrally active phenethylamines.
|
||
|
|
Psychopharm. Commun. 1: 93-98. 75
|
||
|
|
.XP
|
||
|
|
Sargent, T., D. A. Kalbhen, A. T. Shulgin, G. Braun, H. Stauffer, and
|
||
|
|
N. Kusubov. 1975. \fIIn vivo\fR human pharmacodynamics of the
|
||
|
|
psychodysleptic 4-Br-2,5-dimethoxyphenylisopropylamine labelled with
|
||
|
|
\u82\dBr or \u77\dBr. Neuropharmacology 14: 165-174. 76
|
||
|
|
.XP
|
||
|
|
_____. 1975. The chemical catalysis of altered states of consciousness.
|
||
|
|
Altered states of consciousness, current views and research problems.
|
||
|
|
The drug abuse council, Washington, D. C. Pp. 123-134. 77
|
||
|
|
.XP
|
||
|
|
_____. 1975. Drug use and anti-drug legislation. The PharmChem
|
||
|
|
Newsletter 4 (#8). 79
|
||
|
|
.XP
|
||
|
|
_____, and D. C. Dyer. 1975. Psychotomimetic phenylisopropylamines. 5.
|
||
|
|
4-alkyl-2,5-dimethoxyphenylisopropylamines. J. Med. Chem. 18: 1201-1204. 80
|
||
|
|
.XP
|
||
|
|
_____, and C. Helisten. 1975. Differentiation of PCP, TCP, and a
|
||
|
|
contaminating precursor PCC, by thin layer chromatography. Microgram 8:
|
||
|
|
171-172. 81
|
||
|
|
.XP
|
||
|
|
Helisten, C., and A. T. Shulgin. The detection of 1-piperidinodydlohexane-
|
||
|
|
carbonitrile contamination in illicit preparations of 1-(1-phenylcyclohexyl)
|
||
|
|
piperidine and 1-(1-(2-thienyl)cyclohexyl)piperidine. J. Chrom. 117:
|
||
|
|
232-235. 82
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1976. Psychotomimetic agents. \fIIn\fR: M. Gordon [ed.]
|
||
|
|
Psychopharmacological agents, Vol. 4. Academic Press, New York.
|
||
|
|
Pp. 59-146. 83
|
||
|
|
.XP
|
||
|
|
_____. 1976. Abuse of the term "amphetamines". Clin. Tox. 9: 351-352. 84
|
||
|
|
.XP
|
||
|
|
_____. 1976. Profiles of psychedelic drugs. 1. DMT. J. Psychedelic
|
||
|
|
Drugs 8: 167-168. 85
|
||
|
|
.XP
|
||
|
|
_____. 1976. Profiles of psychedelic drugs. 2. TMA-2. J. Psychedelic
|
||
|
|
Drugs 8: 169. 86
|
||
|
|
.XP
|
||
|
|
_____, and D. E. MacLean. 1976. Illicit synthesis of phencyclidine (PCP)
|
||
|
|
and several of its analogs. Clin. Tox. 9: 553-560. 87
|
||
|
|
.XP
|
||
|
|
Nichols, D. E., and A. T. Shulgin. 1976. Sulfur analogs of psychotomimetic
|
||
|
|
amines. J. Pharm. Sci. 65: 1554-1556. 89
|
||
|
|
.XP
|
||
|
|
Sargent, T., A. T. Shulgin, and N. Kusubov. 1976. Quantitative
|
||
|
|
measurement of demethylation of \u14\dC-methoxyl labeled DMPEA and TMA-2
|
||
|
|
in rats. Psychopharm. Commun. 2: 199-206. 90
|
||
|
|
.XP
|
||
|
|
Standridge, R. T., H. G. Howell, J. A. Gylys, R. A. Partyka, and A. T.
|
||
|
|
Shulgin. 1976. Phenylalkylamines with potential psychotherapeutic utility.
|
||
|
|
1. 2-amino-1-(2,5,-dimethoxy-4-methylphenyl)butane. J. Med. Chem.
|
||
|
|
19: 1400-1404. 91
|
||
|
|
.XP
|
||
|
|
_____. 1976. Profiles of psychedelic drugs. 3. MMDA. J. Psychedelic
|
||
|
|
Drugs 8: 331. 92
|
||
|
|
.XP
|
||
|
|
_____. 1977. Profiles of psychedelic drugs. 4. Harmaline. J. Psychedelic
|
||
|
|
Drugs 9: 79-80. 93
|
||
|
|
.XP
|
||
|
|
_____. 1977. Profiles of psychedelic drugs. 5. STP. J. Psychedelic Drugs
|
||
|
|
9: 171-172. 94
|
||
|
|
.XP
|
||
|
|
Nichols, D. E., A. T. Shulgin, and D. C. Dyer. 1977. Directional lipophilic
|
||
|
|
character in a series of psychotomimetic phenethylamine derivatives. Life
|
||
|
|
Sciences 21: 569-576. 95
|
||
|
|
.XP
|
||
|
|
Jacob, P. III, G. Anderson III, C. K. Meshul, A. T. Shulgin, and N.
|
||
|
|
Castagnoli Jr. 1977. Mononethylthio analogues of 1-(2,4,5-trimethoxyphenyl)
|
||
|
|
2-aminopropane. J. Med. Chem. 20: 1235-1239. 96
|
||
|
|
.XP
|
||
|
|
White, T. J., D. Goodman, A. T. Shulgin, N. Castagnoli Jr., R. Lee, and
|
||
|
|
N. L. Petrakis. 1977. Mutagenic activity of some centrally active aromatic
|
||
|
|
amines in \fISalmonella typhimurium\fR. Mutation Research 56: 199-202. 97
|
||
|
|
.XP
|
||
|
|
Braun, U., A. T. Shulgin, G. Braun, and T. Sargent III. 1977. Synthesis
|
||
|
|
and body distribution of several iodine-131 labeled centrally acting
|
||
|
|
drugs. J. Med. Chem. 20: 1543-1546. 98
|
||
|
|
.XP
|
||
|
|
Sargent, T. III, T. F. Budinger, G. Braun, A. T. Shulgin, and U. Braun.
|
||
|
|
1978. An iodated catecholamine congener for brain imaging and metabolic
|
||
|
|
studies. J. Nucl. Med. 19: 71-76. 99
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1978. Psychotomimetic drugs: structure-activity
|
||
|
|
relationships. \fIIn\fR: L. L. Iversen, S. D. Iversen, and S. H. Snyder
|
||
|
|
[eds.], Handbook of psychopharmacology, Vol. 11. Plenum Press, New
|
||
|
|
York. Pp. 243-333.
|
||
|
|
.XP
|
||
|
|
Sargent, T. III, G. Braun, U. Braun, T. F. Budinger, and A. T. Shulgin.
|
||
|
|
1978. Brain and retina uptake of a radio-iodine labeled psychotomimetic
|
||
|
|
in dog and monkey. Commun. Psychopharm. 2: 1-10. 101
|
||
|
|
.XP
|
||
|
|
Braun, G., A. T. Shulgin, and T. Sargent III. 1978. Synthesis of
|
||
|
|
\u123\dI-labelled 4-iodo-2,5-dimethoxyphenylisopropylamine. J. Labelled
|
||
|
|
Comp. and Radiopharm. 14: 767-773. 102
|
||
|
|
.XP
|
||
|
|
Murdock, J. E., J. R. Patty, and A. T. Shulgin. 1978. A novel illicit
|
||
|
|
amphetamine laboratory. Microgram 11: 98-101. 103
|
||
|
|
.XP
|
||
|
|
Anderson, G. M. III, G. Braun, U. Braun, D. E. Nichols, and A. T. Shulgin.
|
||
|
|
1978. Absolute configuration and psychotomimetic activity. \fIIn\fR:
|
||
|
|
G. Barnett, M. Trsic, and R. Willette [eds.], QuaSAR Research Monograph 22.
|
||
|
|
N.I.D.A. Washington, D.C. Pp. 8-15. 104
|
||
|
|
.XP
|
||
|
|
Braun, U., G. Braun, P. Jacob III, D. E. Nichols, and A. T. Shulgin.
|
||
|
|
Mescaline analogs: substitutions at the 4-position. \fIIn\fR:
|
||
|
|
G. Barnett, M. Trsic, and R. Willette [eds.], QuaSAR Research Monograph 22.
|
||
|
|
N.I.D.A. Washington, D.C. Pp. 27-37. 105
|
||
|
|
.XP
|
||
|
|
Partyka, R. A., R. T. Standridge, H. G. Howell, and A. T. Shulgin. 1978.
|
||
|
|
2-amino-1-(2,5-dimethoxyphenyl)butanes. U.S. Patent 4,105,695, issued
|
||
|
|
Aug. 8, 1978. 106
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T., and D. E. Nichols. 1978. Characterization of three new
|
||
|
|
psychotomimetics. \fIIn\fR: R. C. Stillman and R. E. Willette [eds.],
|
||
|
|
The psychopharmacology of hallucinogens. Pergamon Press, New York.
|
||
|
|
Pp. 74-83. 107
|
||
|
|
.XP
|
||
|
|
Glennon, R. A., L. B. Kier, and A. T. Shulgin. 1979. Molecular
|
||
|
|
connectivity analysis of hallucinogenic mescaline analogs. J. Pharm.
|
||
|
|
Sci. 68: 906-907. 108
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1979. Chemistry of phenethylamines related to mescaline.
|
||
|
|
J. Psychedelic Drugs 11: 41-52. 109
|
||
|
|
.XP
|
||
|
|
_____. 1979. Profiles of psychedelic drugs. 6. \fGa\fR,O-DMS.
|
||
|
|
J. Psychedelic Drugs 11: 247. 110
|
||
|
|
.XP
|
||
|
|
_____. 1979. Profiles of psychedelic drugs. 7. Mescaline. J.
|
||
|
|
Psychedelic Drugs 11: 355. 111
|
||
|
|
.XP
|
||
|
|
Standridge, R. T., H. G. Howell, H. A. Tilson, J. H. Chamberlain, H. M.
|
||
|
|
Holava, J. A. Gylys, R. A. Partyka, and A. T. Shulgin. 1980.
|
||
|
|
Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear
|
||
|
|
substituted 2-amino-1-phenylbutanes. J. Med. Chem. 23: 154-162. 112
|
||
|
|
.XP
|
||
|
|
Braun, U., A. T. Shulgin, and G. Braun. 1980. Centrally active
|
||
|
|
N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine
|
||
|
|
(3,4-methylenedioxyamphetamine). J. Pharm. Sci. 69: 192-195. 113
|
||
|
|
.XP
|
||
|
|
Kantor, R. E., S. D. Dudlettes, and A. T. Shulgin. 1980. 5-methoxy-
|
||
|
|
\fGa\fR-methyltryptamine (\fGa\fR,O-dimethylserotonine) a hallucinogenic
|
||
|
|
homolog of serotonin. Biol. Psychiat. 15: 349-352. 114
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1980. Profiles of psychedelic drugs. 8. psilocybin.
|
||
|
|
J. Psychedelic Drugs 12: 79. 115
|
||
|
|
.XP
|
||
|
|
Braun, U., A. T. Shulgin, and G. Braun. 1980. Pru\*:fung auf
|
||
|
|
Aktivita\*:t und Analgesia von N-substituierten Analogen des Amphetamin-
|
||
|
|
Derivates 3,4-Methylendioxyphenylisopropylamin. Arzneim. Forsch.
|
||
|
|
30: 825-830. 116
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1980. Profiles of psychedelic drugs. 9. LSD.
|
||
|
|
J. Psychedelic Drugs 12: 173-174. 117
|
||
|
|
.XP
|
||
|
|
_____. 1981. Hallucinogens. \fIIn\fR: M. E. Wolff [ed.], Burger's
|
||
|
|
medicinal chemistry. Wiley & Co. Pp. 1109-1137.
|
||
|
|
.XP
|
||
|
|
_____. 1981. Profiles of psychedelic drugs. 10. DOB. J. Psychoactive
|
||
|
|
Drugs 13: 99. 119
|
||
|
|
.XP
|
||
|
|
_____, and M. F. Carter. 1981. N,N-diisopropyltryptamine (DIPT) and
|
||
|
|
5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active
|
||
|
|
tryptamine analogs with CNS activity. Commun. Psychopharmacol.
|
||
|
|
4: 363-369. 120
|
||
|
|
.XP
|
||
|
|
Jacob, P., and A. T. Shulgin. 1981. Sulfur analogues of psychotomimetic
|
||
|
|
agents. Monothio analogues of mescaline and isomescaline. J. Med. Chem.
|
||
|
|
24: 1348. 121
|
||
|
|
.XP
|
||
|
|
Domelsmith, L. N., T. A. Eaton, K. N. Houk, G. M. Anderson, R. A. Glennon,
|
||
|
|
A. T. Shulgin, N. Castagnoli, and P. A. Kollman. 1981. Photoelectron
|
||
|
|
spectra of psychotropic drugs. 6. Relationships between physical
|
||
|
|
properties and pharmacological actions of amphetamine analogues.
|
||
|
|
J. Med. Chem. 24: 1414. 122
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1981. Chemistry of psychotomimetics. \fIIn\fR:
|
||
|
|
F. Hoffmeister and G. Stille [eds.], Handbook of experimental pharmacology,
|
||
|
|
Vol. 55/III. Springer-Verlag, Berlin Heidelberg. Pp. 3-29.
|
||
|
|
.XP
|
||
|
|
_____. 1981. Profiles of psychedelic drugs. 11. Bufotenine.
|
||
|
|
J. Psychoactive Drugs 13: 389. 124
|
||
|
|
.XP
|
||
|
|
_____, and P. Jacob. 1982. Potential misrepresentation of 3,4-methylene-
|
||
|
|
dioxyamphetamine (MDA). A toxicological warning. J. Anal. Tox. 6: 71. 127
|
||
|
|
.XP
|
||
|
|
_____, and P. Jacob. 1982. 1-(3,4-methylenedioxyphenyl)-3-aminobutane:
|
||
|
|
a potential toxicological problem. J. Toxicol. - Clin. Toxicol. 19: 109. 12
|
||
|
|
.XP
|
||
|
|
Jacob, P., and A. T. Shulgin. 1983. Sulfur analogues of psychotomimetic
|
||
|
|
agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)- and (2,5-
|
||
|
|
dimethoxy-4-ethylphenyl)-isopropylamine. J. Med. Chem. 26: 746. 130
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1983. Twenty years on an ever-changing quest. \fIIn\fR:
|
||
|
|
L. Grinspoon and J. B. Bakalar [eds.], Psychedelic Reflections. Human
|
||
|
|
Sciences Press, New York. 131
|
||
|
|
.XP
|
||
|
|
Sargent, T., A. T. Shulgin, and C. A. Mathis. 1982. New iodinated
|
||
|
|
amphetamines by rapid synthesis for use as brain blood flow indicators.
|
||
|
|
J. Lab. Cmpds. and Radiopharm. 19: 1307. 132
|
||
|
|
.XP
|
||
|
|
Jacob, P., and A. T. Shulgin. 1984. Sulfur analogues of psychotomimetic
|
||
|
|
agents. 3. The ethyl homologues of mescaline and their monothio analogues.
|
||
|
|
J. Med. Chem. 27: 881-888. 133
|
||
|
|
.XP
|
||
|
|
Sargent, T., A. T. Shulgin, and C. A. Mathis. 1984. Radiohalogen-labeled
|
||
|
|
imaging agents. 3. Compounds for measurement of brain blood flow by
|
||
|
|
emission tomography. J. Med. Chem. 27: 1071-1077. 135
|
||
|
|
.XP
|
||
|
|
Repke, D. B., D. B. Grotjahn, and A. T. Shulgin. 1985. Psychotomimetic
|
||
|
|
N-methyl-N-isopropyltryptamines. Effects of variation of aromatic
|
||
|
|
oxygen substituents. J. Med. Chem. 28: 892. 136
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1985. What is MDMA? PharmChem Newsletter 14: 3
|
||
|
|
(May-June, #3). 137
|
||
|
|
.XP
|
||
|
|
Lemaire, D., P. Jacob, and A. T. Shulgin. 1985. Ring substituted
|
||
|
|
beta-methoxyphenethylamines: a new class of psychotomimetic agents active
|
||
|
|
in man. J. Pharm. Pharmacol. 37: 575. 138
|
||
|
|
.XP
|
||
|
|
Mathis, C. A., T. Sargent, and A. T. Shulgin. 1985. Iodine-122 labeled
|
||
|
|
amphetamine derivatives with potential for PET brain blood-flow studies.
|
||
|
|
J. Nucl. Med. 26: 1295. 139
|
||
|
|
.XP
|
||
|
|
_____, _____, and _____. 1986. Synthesis of 122-I and 125-I-labeled-
|
||
|
|
\fImeta\fR-dimethoxy-N,N-dimethyliodophenylisopropylamines. J. Labelled
|
||
|
|
Comp. Radiopharm. 23: 115. 140
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T., L. A. Shulgin, and P. Jacob. 1986. A protocol for the
|
||
|
|
evaluation of new psychoactive drugs. Methods and Findings in
|
||
|
|
Experimental and Clinical Pharmacology 8: 313. 141
|
||
|
|
.XP
|
||
|
|
Nichols, D. E., A. J. Hoffman, R. A. Oberlender, P. Jacob, and A. T.
|
||
|
|
Shulgin. 1986. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine:
|
||
|
|
representatives of a novel therapeutic class. J. Med. Chem. 29: 2009. 143
|
||
|
|
.XP
|
||
|
|
Mathis, C. A., A. T. Shulgin, Y. Yano, and T. Sargent. 1986. \u18\dF-
|
||
|
|
labelled N,N-dimethylamphetamine analogues for brain imaging studies.
|
||
|
|
Appl. Radiat. Isot. 37: 865. 144
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1986. The background and chemistry of MDMA. J. Psychoactive
|
||
|
|
Drugs 18: 291-304. 145
|
||
|
|
.XP
|
||
|
|
Sargent, T. W., A. T. Shulgin, and C. A. Mathis. 1987. Rapid brain
|
||
|
|
scanning pharmaceutical. U. S. Patent 4,647,446. 146
|
||
|
|
.XP
|
||
|
|
McKenna, D. J., C. A. Mathis, A. T. Shulgin, T. Sargent, and J. M. Saavedra.
|
||
|
|
1987. Autoradiographic localization of binding sites for \u125\dI-DOI,
|
||
|
|
a new psychotomimetic radioligand, in the rat brain. Eur. J. Pharmacol.
|
||
|
|
137: 289-290. 147
|
||
|
|
.XP
|
||
|
|
Shulgin, A. T. 1987. The 'social-chemistry' of pharmacological discovery.
|
||
|
|
Social Pharmacology 1: 279-290. 148
|
||
|
|
.XP
|
||
|
|
_____. 1987. Reference information on MDMA. Analog 9: #4 (page 10). 149
|
||
|
|
.XP
|
||
|
|
_____. 1988. DIPT: the distortion of music. Reality Hackers #6 (Winter
|
||
|
|
1988) p. 27. 152.
|
||
|
|
.XP
|
||
|
|
_____. 1988. THE CONTROLLED SUBSTANCES ACT: A resource manual of the
|
||
|
|
current status of the federal drug laws. 383 pp., published in Lafayette,
|
||
|
|
California 94549 April 1988. 154
|
||
|
|
.XP
|
||
|
|
_____. In press. History of MDMA. \fIIn\fR: S. Peroutka [ed.], MDMA:
|
||
|
|
"Ecstasy" and human neurotoxin? Kluwer Academic Publishers, Norwell, MA,
|
||
|
|
02061.
|
||
|
|
|
||
|
|
|
||
|
|
------end forwarded message----------
|